---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-002241"
form_type: "8-K"
ticker: "BRKR"
cik: "0001109354"
company_name: "BRUKER CORP"
filed_at: "2023-02-09T23:59:59+00:00"
generated_at: "2026-06-19T19:14:59.057412+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Bruker Q4 non-GAAP EPS $0.74 (+25% YoY); FY23 organic growth guidance 8-10%

## Summary
- Q4 revenues $708.4M (+3.6% reported, +8.9% organic); GAAP EPS $0.66 vs $0.50.
- FY22 revenues $2.531B (+4.7% reported, +10.2% organic); non-GAAP EPS $2.34 (+11.4%).
- FY23 guidance: revenue $2.81-2.86B (8-10% organic); non-GAAP EPS $2.52-2.57 (8-10% growth).
- BSI organic growth 9.5% (FY); BEST organic growth 17.4%; non-GAAP op margin expanded to 20.0%.
- Management cites double-digit organic bookings growth and accelerated investments in proteomics.

## SEC filing metadata
- accession: 0000950170-23-002241
- form_type: 8-K
- ticker: BRKR
- cik: 0001109354
- company_name: BRUKER CORP
- filed_at: 2023-02-09T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1109354/000095017023002241/0000950170-23-002241-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1109354/000095017023002241/brkr-20230209.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-002241
- JSON: https://secwatch.observer/filing/0000950170-23-002241.json
- Plain text: https://secwatch.observer/filing/0000950170-23-002241.txt

## Key facts
- Earnings Releases
  BRUKER CORP reported the three months ended December 31, 2022 results: revenue $708.4 million, EPS $0.66.
  - Period: the three months ended December 31, 2022
  - Revenue: $708.4 million
  - EPS: $0.66
  - Result: reported results
  source text: 9 – Financial Statements and Exhibits --- EX-99.1 (EX-99.1) --- EX-99.1 Exhibit 99.1 Bruker Reports Fourth Quarter and Fiscal Year 2022 Financial Results • Q4 2022 revenues $708.4 million, up 3.6% year-over-year (yoy); organic revenue growth of 8.9% • Q4 2022 GAAP EPS $0.66; non-GAAP EPS $0.74, up 25.4% yoy • FY 2022 revenues $2.531 billion, up 4.7% yoy; organic
  evidence_url: https://www.sec.gov/Archives/edgar/data/1109354/000095017023002241/0000950170-23-002241-index.htm
- Earnings Releases
  BRUKER CORP reported FY 2023 results: revenue $2.81 to $2.86 billion, EPS $2.52 to $2.57. Guidance initiated.
  - Period: FY 2023
  - Revenue: $2.81 to $2.86 billion
  - EPS: $2.52 to $2.57
  - Guidance: initiated
  - Result: guidance update
  source text: For FY 2023, Bruker expects revenue of $2.81 to $2.86 billion, or 11% to 13% year-over-year reported revenue growth
  evidence_url: https://www.sec.gov/Archives/edgar/data/1109354/000095017023002241/0000950170-23-002241-index.htm
- Earnings Releases
  BRUKER CORP reported the year ended December 31, 2022 results: revenue $2.531 billion, EPS $1.99.
  - Period: the year ended December 31, 2022
  - Revenue: $2.531 billion
  - EPS: $1.99
  - Result: reported results
  source text: • Q4 2022 revenues $708.4 million, up 3.6% year-over-year (yoy); organic revenue growth of 8.9% • Q4 2022 GAAP EPS $0.66; non-GAAP EPS $0.74, up 25.4% yoy • FY 2022 revenues $2.531 billion, up 4.7% yoy; organic revenue growth of 10.2% • FY 2022 GAAP EPS $1.99; non-GAAP EPS $2.34, up 11.4% yoy • Bruker expects FY 2023 organic revenue growth of 8% to 10% yoy
  evidence_url: https://www.sec.gov/Archives/edgar/data/1109354/000095017023002241/0000950170-23-002241-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.